Inventor · disambiguated record
Tianan Fang
Also filed as: FANG TIANAN
24 granted patents·7 pending applications·138 citations·filing 2005–2024
95Inventor score
Top patents by PatentIndex Score
31 records- 0197US10576062B2Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonistsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Mar 3, 2020·18 cites·18 claims
- 0296US10071078B2Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonistsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Sep 11, 2018·21 cites·16 claims
- 0396US9453018B2Pyrimidinones as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Sep 27, 2016·13 cites·17 claims
- 0494US11007180B2Carbamoyloxymethyl triazole cyclohexyl acids as LPA antagonistsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted May 18, 2021·3 cites·1 claims
- 0592US9902742B2Macrocycles as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Feb 27, 2018·5 cites·13 claims
- 0692US9611274B2Macrocycles as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Apr 4, 2017·5 cites·14 claims
- 0791US10487086B2Macrocycles as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2017·Granted Nov 26, 2019·3 cites·9 claims
- 0891US9221818B2Macrocycles as factor XIa inhibitorsPINTO DONALD J P·Filed 2012·Granted Dec 29, 2015·13 cites·11 claims
- 0991US8940720B2Macrocycles as factor XIa inhibitorsCORTE JAMES R·Filed 2011·Granted Jan 27, 2015·6 cites·4 claims
- 1091US7429604B2Six-membered heterocycles useful as serine protease inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2005·Granted Sep 30, 2008·35 cites·20 claims
- 1189US9802939B2Macrocycles as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2014·Granted Oct 31, 2017·3 cites·9 claims
- 1288US2025057815A1Carbamoyloxymethyl triazole cyclohexyl acids as lpa antagonistsBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 1387US11053247B2Pyrimidinones as factor XIA inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Jul 6, 2021·2 cites·9 claims
- 1486US11136327B2Macrocycles as factor XIA inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Oct 5, 2021·1 cites·11 claims
- 1586US10336754B2Pyrimidinones as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jul 2, 2019·2 cites·17 claims
- 1686US2023390249A1Carbamoyloxymethyl triazole cyclohexyl acids as lpa antagonistsBRISTOL MYERS SQUIBB CO·Filed 2023·Application pending·0 cites
- 1781US11352345B2Cyclohexyl acid pyrazole azoles as LPA antagonistsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Jun 7, 2022·1 cites·3 claims
- 1881US11267800B2Cyclohexyl acid triazole azines as LPA antagonistsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Mar 8, 2022·2 cites·31 claims
- 1980US12404274B2Macrocycles as factor xia inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Sep 2, 2025·0 cites·8 claims
- 2079US2022249443A1Carbamoyloxymethyl triazole cyclohexyl acids as lpa antagonistsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 2178US9777001B2Macrocycles with aromatic P2′ groups as factor xia inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Oct 3, 2017·3 cites·11 claims
- 2277US12428421B2Pyrimidinones as factor XIA inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2021·Granted Sep 30, 2025·0 cites·31 claims
- 2375US2021244711A1Carbamoyloxymethyl triazole cyclohexyl acids as lpa antagonistsBRISTOL MYERS SQUIBB CO·Filed 2021·Application pending·0 cites
- 2474US9409908B2Dihydropyridone p1 as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2013·Granted Aug 9, 2016·1 cites·14 claims
- 2573USRE49352ECarbamoyloxymethyl triazole cyclohexyl acids as LPA antagonistsBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Jan 3, 2023·0 cites·25 claims
- 2672US11319315B2Cyclohexyl acid triazole azoles as LPA antagonistsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted May 3, 2022·1 cites·30 claims
- 2761US2016368923A1Pyrimidinones as factor xia inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Application pending·0 cites
- 2859US10273236B2Macrocyclic factor XIa inhibitors bearing heterocyclic groupsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Apr 30, 2019·0 cites·11 claims
- 2954US9951071B2Dihydropyridone P1 as factor XIa inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2016·Granted Apr 24, 2018·0 cites·7 claims
- 3054US2017342071A1Macrocyclic factor xia inhibitors condensed with heterocyclesBRISTOL MYERS SQUIBB CO·Filed 2017·Application pending·0 cites
- 3146US2017057961A1Macrocyclic factor xia inhibitors condensed with heterocyclesBRISTOL MYERS SQUIBB CO·Filed 2015·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Tianan Fang files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →